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Summary
Objective: The International Medical Informatics Association 
(IMIA) Open Source Working Group (OSWG) initiated a group 
discussion to discuss current privacy and security issues in the 
open data movement in the healthcare domain from the perspec-
tive of the OSWG membership.
Methods: Working group members independently reviewed the 
recent academic and grey literature and sampled a number of 
current large-scale open data projects to inform the working 
group discussion. 
Results: This paper presents an overview of open data reposito-
ries and a series of short case reports to highlight relevant issues 
present in the recent literature concerning the adoption of open 
approaches to sharing healthcare datasets. Important themes 
that emerged included data standardisation, the inter-connected 
nature of the open source and open data movements, and how 
publishing open data can impact on the ethics, security, and 
privacy of informatics projects.
Conclusions: The open data and open source movements in 
healthcare share many common philosophies and approaches 
including developing international collaborations across multiple 
organisations and domains of expertise. Both movements aim to 
reduce the costs of advancing scientific research and improving 
healthcare provision for people around the world by adopting 
open intellectual property licence agreements and codes of 
practice. Implications of the increased adoption of open data in 
healthcare include the need to balance the security and privacy 
challenges of opening data sources with the potential benefits of 
open data for improving research and healthcare delivery.
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1   Introduction
The International Medical Informatics Asso-
ciation (IMIA) Open Source Working Group 
(OSWG) is a voluntary group supported by 
IMIA that brings together researchers and prac-
titioners from multiple countries with a diverse 
range of informatics experience but common 
interest in the adoption of open approaches to 
advancing the use of informatics to improve 
healthcare. Although not engaged on a com-
mon research project, working group members 
foster international discussions and debates on 
current issues related to the adoption of open 
source approaches and have supported the de-
velopment of an open access database of Free, 
Libre, and Open Source Software (FLOSS), 
called MedFLOSS (www.medfloss.org), to be 
used in the medical domain.
In response to the theme of the 2018 
issue of the IMIA yearbook, “Sharing data: 
balancing access and privacy to advance 
healthcare”, the IMIA OSWG members have 
collaborated on a working group discussion 
to discuss the interplay and commonalities 
between the open source and open data 
movements in the healthcare domain.
The openness of software has accelerated 
innovation in recent decades [1–3]. FLOSS 
has been widely used as an infrastructure 
for powering in the Internet and has also 
been widely adopted in the medical domain 
[4–6]. This trend towards openness in soft-
ware development is now being applied to 
the publication of datasets. In recent years, 
datasets have been opened to the public un-
der FLOSS-like licences on the Internet as 
“open data” [7]. There is still some debate 
about the definition of “open data” but, in 
general, “open data” is the phrase that has 
come to mean available “for anyone to use, 
for any purpose, at no cost” [8].
The Open Knowledge Foundation (OKF) 
has defined “open data” as datasets released 
with these conditions:
1. Availability and access: the data must 
be available as a whole and at no more than 
a reasonable reproduction cost, preferably 
by downloading over the Internet. The data 
must also be available in a convenient and 
modifiable form;
2. Reuse and redistribution: the data must 
be provided under terms that permit reuse 
and redistribution including the intermix-
ing with other datasets. The data must be 
machine-readable;
3. Universal participation: everyone must 
be able to use, reuse, and redistribute — there 
should be no discrimination against fields 
of endeavour or against persons or groups. 
For example, ‘non-commercial’ restrictions 
that would prevent ‘commercial’ use, or 
restrictions of use for certain purposes (e.g. 
only in education), are not allowed.
In this article, the term “open data” follows 
the OKF definition.
The open data movement has rapidly 
spread across the world since Barack Obama 
issued his memorandum on transparency and 
open government in 2009, which emphasized 
how openness would strengthen democracy 
and promote government efficiency and ef-
fectiveness [9]. Following this memorandum, 
the US government implemented a Web-based 
platform to open their data called Data.Gov 
[10]. Other countries followed this activity 
and there are now many open data websites 
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operated by governments around the world. 
The social coding website, GitHub, now hosts 
a wide range of open source tools to manipu-
late open data and the site is frequently used 
by the open data community to discuss imple-
mentation guides, data requirements, and other 
processes needed to use open data effectively 
[11]. There are various FLOSS tools to utilize 
“open data”, such as geographical mapping 
tools [12] and tools for genetic analysis [13], 
and there are now a wide range of internet 
companies using open data to create online 
services such as Citymappers and Transport 
for London who use these open data sources 
to provide visualised information [14, 15]. The 
beneficial economic effect of open data has 
been estimated to be between 3 to 5 trillion 
USD per year, in the global economy, and 
the use of open data in health care has been 
claimed to save 450-550 billion USD per 
year in US [16]. The European commission 
estimated the total market size of “open data” 
to between 193 and 209 billion EUR for 2016, 
and expected this figure to grow by 36.9% by 
2020 in the EU 28+ [17].
In the scientific domain, genomics data 
have been made open through internet re-
positories and these have accelerated the 
completion of the human genome project 
[18] and cultivated a wide range of bioinfor-
matics and other -omics research through the 
availability of data [19] computer science, 
mathematics, and statistics. Data intensive, 
large-scale biological problems are addressed 
from a computational point of view. The most 
common problems are modeling biological 
processes at the molecular level and making 
inferences from collected data. A bioinfor-
matics solution usually involves the following 
steps: Collect statistics from biological data. 
Build a computational model. Solve a compu-
tational modeling problem. Test and evaluate 
a computational algorithm. This chapter gives 
a brief introduction to bioinformatics by first 
providing an introduction to biological ter-
minology and then discussing some classical 
bioinformatics problems organized by the 
types of data sources. Sequence analysis is 
the analysis of DNA and protein sequences for 
clues regarding function and includes subprob-
lems such as identification of homologs, mul-
tiple sequence alignment, searching sequence 
patterns, and evolutionary analyses. Protein 
structures are three-dimensional data and the 
associated problems are structure prediction 
(secondary and tertiary. Free access to scien-
tific databases has supported a wide range of 
large-scale scientific projects globally and is 
now largely regarded as part of the information 
technology (IT) infrastructure for many proj-
ects. Organisation for Economic Co-operation 
and Development (OECD) guidelines have 
described these beneficial effects of open data 
and now promote the disclosure of research 
data from public-funded projects to maximise 
the effects of government investment [20].
Healthcare data usually contains sensi-
tive information that needs to be protected 
for privacy reasons, which, at first thought, 
may be considered as a barrier to openness. 
However, many non-healthcare open data 
repositories already contain human subject 
data and open data availability is increasing-
ly being adopted in healthcare despite this 
concern. There are now rising pressures to 
adopt open data for research and healthcare 
operational transparency but the use of open 
data will still require a careful balancing of 
free access and privacy in order to protect 
healthcare clients’ confidentiality [8, 21]. 
This is because although we would like the 
patient to have access to his or her own data, 
we also want to preserve the right for any 
patient to keep his or her health data private 
if (s)he so wishes. This is highlighted in the 
“second pillar” of the Estonian e-Society 
[22] which states that citizens can have 
access to their data records but that other 
government agencies have access to the data 
only if the citizen authorises access via his or 
her personalised digital signature.
Citizens’ right to personal privacy has been 
extended to patients by physicians from the 
time of Hippocrates of Cos (400 B.C.), who 
established a school of medicine and expected 
medical practitioners to subscribe to a medical 
oath, now known as the Hippocratic oath [23], 
essential variants of which are still in use today. 
New clinicians promise that “whatsoever I shall 
see or hear in the course of my profession, as 
well as outside my profession in my intercourse 
with men, if it be what should not be published 
abroad, I will never divulge, holding such 
things to be holy secrets”.
The oath’s respect for privacy and human 
dignity also has a medical dimension: “I will 
use treatment to help the sick according to 
my ability and judgment, but never with a 
view to injury and wrong-doing.” This can be 
relevant in situations where a patient’s health 
may be adversely affected by having little or 
no control over his or her own medical privacy 
[24], or where societal forces allow employers 
to pursue an expectation of having access 
to personal medical data by presuming that 
employee medical data will be made available 
to them because they can buy it, or because 
they can expect all medical data of their em-
ployees to be made open to them. The new 
General Data Protection Regulation coming 
into force to the state members of European 
Union in 2018 [25] will threaten worldwide 
companies with large fines if they misuse 
personal data from Europe. Alongside data 
protection issues, there arise questions about 
the use of medical health data that categorise 
individuals [26] by commercial organisations. 
And yet, at the same time, perhaps there are 
medical details patients will want to share, for 
purposes of medical research [27]. Perhaps, 
too, patients would like to have access to all 
of their own medical data.
With the topic of this year’s Yearbook 
of Medical Informatics issue being how to 
balance the various requirements of the var-
ious stakeholders in medical health data, an 
important medico-socio-technical issue can 
be seen as one of seeking to allow persons 
comprehensive access to their own medical 
data, where their own interests are served, 
and using healthcare data to improve med-
ical research and healthcare delivery while 
protecting their medical data privacy, where 
it is medically justifiable to do so.
2   Methods
Through a combination of Open Source 
Working Group discussions and desk re-
search, we selected a number of existing 
open healthcare data repositories to serve as 
examples of the types of standards and ap-
proaches to open data in healthcare. Working 
group members also independently reviewed 
recent issues and controversies surrounding 
the open data movement to produce a series 
of mini-case studies.
We evaluated whether health data reposi-
tories meet the OKF open definition [28] in 
the following categories:
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1. Open licence;
2. Free accessibility;
3. Machine readability;
4. Open format.
Licences must be public domain or com-
patible with open licences and should be 
downloadable via the Internet at reasonable 
cost. The data should be in a machine-read-
able form that can be easily processed by a 
computer using an open data format [28].
Through a snowball sampling tech-
nique, we aimed to discover open data 
repositories in use in healthcare by exam-
ining grey and white literature retrieved 
from internet searching by keywords, 
such as “open data health”, journal data-
base searches, and the Open Health Data 
Journal recommendations [29]. While the 
“data portal” site [30] shows 524 open data 
repositories, we sampled 13 data reposi-
tories that include healthcare data shown 
below (Table 1) as examples. 
Table 1   Health Data Repositories and their profiles.
3   Results
Table 1 shows an overview of each of the 
example healthcare data repositories and how 
they align with the openness principles de-
fined by the OKF which we summarise here:
Organisation
The maintenance of the majority of the 
data repositories identified was performed 
by local or national governments, or both 
working together. Repositories #3, #8, #9, 
#10, #11, and #13 were maintained by ac-
ademic groups. The remaining repositories 
#1, #2, and #6 are “mash-up” sites that 
collect relevant data repositories of their 
nations to provide each dataset.
Repository #11 is a data repository site for 
researchers that enables them to freely share 
data within a size limit in a private repository 
and provides unlimited storage with open 
conditions. If users need more storage over 
the limit, a premium service is also available.
Data Categorisation
Every data repository reviewed has various 
categories of data, such as public health, ep-
idemiological data, health services, disease 
distribution (by age groups, areas, or other 
risk factors), profiles of healthcare providers, 
and geolocation of hospitals.
Data Accessibility
All data sets were accessible via the Internet 
without any charge. Most of the data sets could 
be opened and freely downloaded, but the 
repositories #3, #9, and #12 requested registra-
tion or permission in order to download data.
Repositories #1, #2, #9, #10, and #11 also 
provide data via web application program-
ming interface (API) for developers to query 
data programmatically. One example of open 
data API use is the rHealthDataGov project 
on GitHub which enables API access to 
HealthData.gov for users of the R statistical 
analysis package [31].
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
Data repository 
name
HealthData.gov
DATA.GOV.UK
The human 
mortality database
Global health 
observatory data
Big cities health 
coalition
DATA GO JP
Dryad
UKDA
Physionet
Open Health Data 
dataverse
Figshare
SND
eResearch South 
Australia
Issuer
U.S. Department of Health & 
Human Services
United Kingdom, government 
digital service
The Human Mortality              
Database Project
World Health Organisation
A forum for the leaders of 
America’s largest metropolitan 
health departments
Cabinet secretariat of Japan
Non-profit organisation
Academic group
NIH granted project
Harvard university
Academic group
Swedish national data service
Joint venture of universities
URL
https://www.healthdata.gov/
https://data.gov.uk/
http://www.mortality.org/
http://www.who.int/gho/
database/en/
https://bchi.bigcitieshealth.org/
http://www.data.go.jp
http://datadryad.org
http://www.data-archive.ac.uk
http://www.physionet.org
https://dataverse.harvard.edu/
dataverse/openhealthdata
https://figshare.com/
https://snd.gu.se/sv
https://data.sa.edu.au/
Accessibility
open
open
registration required
open
open
open
open
open
open but partial 
registration required
open
open
permission required
open
License
open
open
not open
not open
not explicit
open
open
open
open
not open
open
not explicit
open
Machine 
readability
3531/3542
2121/2132
12103
>1000
53/53
112/624
974/974
>1502
>111
About 62900
(more than 40)
0
1
Available formats
JSON, CSV, XML, RDF
CSV, XLS, HTML
CSV
JSON, CSV, XML, XLS
CSV
CLS, HTML, PDF
XLS, MATLAB, RMD, SOLR
PDF, XLSX, CSV
R, MATLAB, Database, API
Text, CSV, XSLC, R, SPSS
CSV, XSLX
- 
Text
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License
Repositories #1, #2, #6, #8, #9, #10, #11, and 
#13 have open licenses that satisfy the open 
data definition, such as Creative Commons 
CC-BY [32], Open Data Commons Open 
Database Licence [33], or other open licences. 
Other sites did not show explicit information 
on the licences used for data distribution or 
modification.
Even though most of the datasets contained 
in the repositories described were released un-
der open licences on “open data” repositories, 
some of the datasets were not published under 
open licences, because of legal restrictions 
related to the governance of health data.
Machine Readability, Available Formats
In most of the sites, common data formats 
such as CSV (Comma Separated Values), or 
exchange data formats such as JSON (JavaS-
cript Object Notation), and XML (eXtensible 
Markup Language) are available. The number 
of formats were categorized in #1, #2, and #6, 
but not shown in other sites. However, some 
of the datasets provide only PDF (Portable 
Document Format). For example, repository 
#6 provides 624 datasets, but 512 of them are 
in PDF format. Therefore, only 112 of 624 
datasets were available as machine-readable 
formats. Even though PDF is an ISO 32000-2 
standardized format, it is not a preferred option 
for processing data for analysis by most scien-
tists. There are also many datasets published 
in spreadsheets using the XLS format that is 
widely used in Microsoft Excel 2003 or earlier. 
Since the specification of XLS format is openly 
published by Microsoft Corporation [34], it 
might be categorized as an open format. The 
Office Open XML format, that was adopted 
in Microsoft Excel 2007 or later, is one of the 
ISO standards [35] but it was less frequently 
adopted than XLS in published datasets. 
Data Protection
There are more than 80,000 open datasets in 
all the repositories we identified but person-
ally identifiable information was not found in 
the example database we selected although 
more detailed analysis is needed to confirm 
this. Repositories #1, #2, #4, #6, #7, #10, #11, 
and #12 addressed their privacy policy to their 
datasets, and we could not identify any fault 
against their policies in their datasets.
4   Case Studies
The Working Group discussion and individ-
ual working group member desk reviews 
identified a number of Case Studies that 
serve to highlight common themes related to 
the adoption of open data in healthcare, and 
ethical issues about how medical data sets are 
shared, used, and reused by various agencies.
4.1   Case 1 - Care Providers and 
Global Businesses
Accenture PLC [36] is one of the largest 
consulting companies in the world. When ana-
lysing the medical domain, they found various 
forms of disruption entering the industry over 
the next decade [37]. For example, Accenture 
found examples of device companies (such 
as hearing-aid suppliers) and pharmaceutical 
companies turning towards service support. 
They also found that new partnerships devel-
oped between digital companies, healthcare 
providers, and service support industries. There 
seems to be a particular interest for advanced 
cognitive systems such as IBM Watson [38], 
in areas such as genomics, oncology, care 
management, and drug discovery. Google’s 
DeepMind Health systems are being employed 
to serve patients, nurses, and doctors [39]. The 
DeepMind “Streams” app, for example, allows 
clinicians to be informed when patient vital 
signs deteriorate using data from patient-mon-
itoring technology that deliver in real-time 
significant patient life-sign indicators to the 
clinician’s mobile device. The potential for such 
support, particularly in developing countries, 
has been highlighted as a major medical benefit. 
Many of these big data and cognitive solutions 
are proprietary technologies which are engaged 
under contract. Ethical questions regarding pol-
icy, data ownership, and data usage by national 
governments and private solution providers 
arise. Deployment of free and open source 
eHealth solutions may take a greater national 
importance when considered as an option to 
national implementations in this environment.
4.2   Case 2 - Medical Data Aggregated 
with Data from Other Sources
In 2003, NHS England launched care.data 
[40] in order to combine all healthcare re-
cords stored by general practitioners with 
all information stored by social services and 
hospitals, the data being loaded into national 
Health and Social Care Information Centre 
(HSCIC) databases. Another aspect of HSCIC 
databases is the Hospital Episode Statistics 
dataset which collects and collates data from 
125 million individual inpatients, outpatients, 
and Accident and Emergency records yearly in 
England. Questions naturally arise regarding 
how this data will be combined, how it will 
be used, under what circumstances it needs to 
be anonymised, and whether it can be anony-
mised. National implementers face numerous 
eHealth medical, ethical, and governance chal-
lenges [41, 42], and a range of tools for framing 
questions is emerging [43, 44]. These difficult 
issues aside, national healthcare providers who 
have made significant movements in healthcare 
include Estonia, Sweden, Norway, Denmark, 
Japan, Canada, and England. More research 
is needed to compare and contrast the merits 
and demerits of various approaches taken by 
national governments.
4.3   Case 3 – Selling Medical Data 
to Commercial Organisations
Care.data has been a valuable research re-
source for such tasks as resource allocation 
and monitoring of treatment effectiveness. 
Controversially, the combined data was made 
available to pharmaceutical companies, in-
surance companies, health charities, hospital 
trusts, think tanks, and other private compa-
nies. In 2014, as part of an audit of sales, it 
was disclosed that anonymous, pseudony-
mous, and identifiable data was sold to 160 
organisations [40]. In response to a Freedom 
of Information request [45], HSCIC stated: 
“We recognise that there will however remain 
a latent risk that when combined with other 
sources of data, the identity of the individual 
may be ascertained”. Questions arise regard-
ing the importance of anonymisation, and the 
suitability of pseudonymisation in cases where 
pseudonymisation does not protect the identity 
of patients from commercial organisations. 
Regarding the responsibility of organ-
isations such as HSCIC in their provision 
of anonymous and pseudonymous data, the 
Article 29 working party [46] has specified 
that “to identify if a person is identifiable, ac-
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count should be taken of all the means likely 
reasonably to be used either by the controller 
or by any other person to identify the said 
person.” Questions regarding commitment 
to patient data security arise.
4.4   Case 4 - Patient, Treatment, 
Research, and Citizen’s Rights
In a case from 2008, a patient who had 
suffered a life-threatening cancer as a youth 
[24] later became a clinician. Details of 
the patient’s condition were passed on to 
researchers, and researchers subjected the 
adult clinician to intrusive and upsetting 
telephone calls in the name of research. The 
clinician complained to the hospital where 
the researchers were based, but no action 
was taken to remove the patient from their 
register. Eventually, through recourse to the 
law, the situation was resolved. The hospital 
apologised for its treatment of the clinician 
and removed the clinician’s name from the 
register. The hospital, in its apology, noted that 
the concept of medical confidentiality is par-
amount. Questions arise regarding the steps 
patients need to take to ensure their wishes 
and data security are respected so that their 
previous illnesses don’t cause them further 
distress after treatment has ended.
4.5   Case 5 - Responding to 
Concerns, Learning Lessons
Because of numerous concerns, opt-outs (over 
1 million people, including 40% of GPs) and 
governmental criticisms, and following a gov-
ernment review of care.data [26], care.data was 
closed down in July 2016. However, bringing 
together social records, hospital records, and 
general practitioner records is ongoing. One 
of the outcomes from the DeepMind work, 
the Streams app, which allows clinicians to 
remain informed of a patient’s life signs, has 
been so successful that Taunton and Somerset 
NHS Foundation Trust and DeepMind Health-
care signed a 5-year contract in June 2017 to 
develop and evaluate a system able to detect 
early signs of kidney-failure [47]. Taunton 
and Somerset have been pioneers in the use of 
open source software, with their contract with 
IMS Maxim. That said, there are many ethical 
questions still outstanding. Over 1.6 million 
live NHS data records were given to Google, 
via DeepMind, inappropriately, and it is neither 
clear what other such mistakes will be made, 
nor how the business relationship will develop 
over the years between DeepMind, Google, and 
NHS England. In this regard, it is encouraging 
to note the emergence of an ethics unit within 
DeepMind Health Systems [47]. Important 
questions arise over how to learn lessons from 
past failures as technical rollouts proceed and 
whether sophisticated business information 
system solutions, as they become the norm, 
will be at odds with ethical considerations and, 
in particular, the Hippocratic oath.
These questions are pertinent to a new 
age of digitised medical health provision. 
Where service providers need to find a bal-
ance between data security, data openness, 
and citizen data rights, such cases can help 
us to focus attention on important ethical 
questions. Strong opinions need to be 
traded one against the other in a dialectical 
process in which all data stakeholders are 
sufficiently represented. 
5   Discussion
We outlined some of the key “open data” 
repositories in the healthcare domain and 
reviewed recent cases that highlight the 
privacy and security issues associated with 
open data. The main concerns around “open 
data” are how to manage the benefits and 
transparency effects that we discuss below.
The open data movement has been pro-
ductive for a positive cycle of creation for 
both datasets and tools [7]. Even though the 
spectrum of datasets for open data is different 
from person identifiable data sets (Figure 1), 
there is frequent scepticism about open health 
data initiatives. Questions that arise here are not 
only those about mixing open data with private 
medical information, there are also questions 
about providing commercial organisations with 
live patient data that could be used in a business 
space, for business advantage.
To protect individual privacy, open data 
repositories set their own privacy rules 
and usually oblige data issuers to perform 
de-identification, pseudonymisation, and 
anonymisation. From the open government 
memorandum of Barack Obama, legislation 
was advanced for US, EU, and other countries 
as safeguards [48]. For example, opt-out rules 
from private data collections were obligated 
in many countries. However, there are dif-
ferences between the privacy regulation of 
the EU [25] and the US [49, 50]. Since data 
sources are distributed worldwide, privacy 
legislation needs to be harmonized over 
countries or regions.
Even though health data sets are freely 
available, five out of 13 of the repositories 
did not provide datasets under open licences. 
Some of them addressed publication guides 
for research but there were no explicit licences 
for secondary use of their datasets. While 
these data repositories are primarily designed 
to use data for research which is published 
in the academic arena, open data have also 
been used to develop software to visualize 
the datasets with or without analysis. In 2011, 
open data were used to facilitate emergency 
responses to disasters. After the east Japan 
earthquake, OpenStreetMap [12] was used 
to share the disaster information for logistics 
with victims [51]. In the same year, Hurricane 
Irene approached New York city and nursing 
home capability data were used to build a plan 
to optimize the evacuates [52]
Because health data contains sensitive 
private information, the level of openness of 
health datasets needs to be restricted. Most 
of the data for clinical research cannot be 
opened because the data needs to be person 
identifiable to be clinically useful. Another 
issue that has been problematic recently 
is data fraud in clinical research [53]. The 
International Committee of Medical Journal 
Editors (ICMJE) proposed a data sharing 
framework for clinical trials to improve the 
transparency for research [54]. An open data 
approach might help to build up such frame-
works for transparency of clinical trials.
One of the most widely discussed con-
troversies is about who owns the data in 
healthcare data repositories. Consensus is 
building that personal data should belong 
to each person, but population data could be 
considered as a resource of communities or 
societies. Since the open data movement is 
such a social movement, sharing de-identi-
fied or anonymised health data as open data 
could be an approach to advocate eHealth 
for new generations.
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6   Conclusion
Many aspects of the open data movement 
originated from the open source software 
movement with the aims of improving 
transparency and fostering innovation. 
The benefits of open data have been es-
tablished in many cases and, as health 
data are increasingly included in open 
data repositories, issues of anonymisation 
and de-identification need to be addressed 
and appropriately managed. The open data 
and open source movements share many 
common philosophies and approaches 
including using developing international 
collaborations across multiple organisations 
and domains of expertise. Both movements 
aim to reduce the costs of advancing sci-
entific research and improving healthcare 
provision for people around the world by 
developing intellectual property licence 
agreements and codes of practice that are 
increasingly being adopted in the software 
development and scientific communities.
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